|
Home > Partners |  Print Page |
 Send Page |
Font size |   |
Partners
The GEN2PHEN Consortium constitutes a talented pool of European research groups and companies that are interested in the G2P databasing challenges. A few non-EU participants have been included to bring extra capabilities to the initiative.
University of Leicester (ULEIC), UK. Anthony J Brookes
European Molecular Biology Laboratory - The European Bioinformatics Institute (EBI - EMBL), Germany. Paul Flicek; Helen Parkinson
Fundació IMIM (FIMIM), Spain. Carlos Díaz
Leiden University Medical Center (LUMC), Netherlands. Johan den Dunnen
Institut National de la Santé et de la Recherche Médicale (INSERM), France. Anne Cambon-Thomsen; Christophe Béroud
Karolinska Institutet (KI), Sweden. Jan-Eric Litton
Foundation for Research and Technology (FORTH), Greece. Giorgos Potamias
Commissariat à l’Energie Atomique (CEA), France. Mark Lathrop
Erasmus University Medical Center (EMC), Netherlands. George Patrinos
Institute for Molecular Medicine Finland, University of Helsinki (UHFCG), Finland. Juha Muilu
University of Aveiro – IEETA (UAVR), Portugal. José Luis Oliveira
University of Western Cape (UWC), South Africa. Heikki Lehväslaiho
Council of Scientific and Industrial Research (CSIR), India. Samir K Brahmachari. Institute of Genomics and Integrative Biology (IGIB). Debasis Dash
Swiss Institute of Bioinformatics (SIB), Switzerland. Amos Bairoch
University of Manchester (UNIMAN), UK. Rob Elles
BioBase GmbH (BIOBASE), Germany. Edgar Wingender
deCODE genetics ehf (deCODE), Iceland. Hakon Gudbjartsson
PhenoSystems SA (PHENO), Belgium. David Atlan
Biocomputing Platforms Ltd Oy (BCP), Finland. Timo Kanninen
